Further, since pro-oncogenic TSPY expression has been documented in selected HCC specimens [8], it could exert a male-specific effect(s) on the overall complex etiology for HBV-associated HCC in addition to inactivation mutation of its X-homologue, TSPX. Here, TSPYL2 is linked to hepatocellular carcinoma.